UNSPSC 51284150: Ceftriaxone sodium

This classification denotes a cephalosporin antibiotic with the molecular formula 2C18H16N8O7S3.4Na.7H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 023Z5BR09K, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, disodium salt, (6r-(6alpha,7beta(z)))- but more generally known as ceftriaxone sodium, which bears US NIH Compound Identifier 9570832.

UNSPSC 51284150 Ceftriaxone sodium is a Commodity code under which state and local governments procure injectable antibiotics and related pharmaceutical products, though recent opportunities show substantial tagging mismatch — the code appears to capture a narrow antibiotic product class while solicitations tagged to it span naloxone delivery systems, broad-based medical and first aid supplies for emergency response, multi-state generic pharmaceutical procurement, and direct-to-manufacturer prescription programs. The actual buying under this code's tag includes emergency medical consumables (respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, bandaging materials, oxygen delivery systems), naloxone and drug deactivation systems for community health, and generic multi-source pharmaceuticals distributed through state and local health systems. Issuing bodies include county health departments (Seminole County, Florida), city fire and rescue divisions (City of Tampa), state health and human services agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across multiple jurisdictions including Oregon).

Geographic activity centers on Florida, Texas, and Minnesota, with broader multi-state reach through cooperative purchasing vehicles. Representative recent opportunities include Seminole County's IFB 60459723LAS (due July 26, 2023) for 1,900 units of naloxone and 800 drug deactivation systems with annual renewals and estimated fixed-fee pricing; the City of Tampa's IFB 26-P-00145 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000 and designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000; the Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802 (due March 26, 2026) to establish multiple-award contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities, with contract term of two years and optional extensions; and the Texas Health and Human Services Commission RFI HHS0017013 (due April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities for a Therapeutic Pharmacy Initiative program. The code's recent-opportunity record shows substantial misalignment between its nominal scope and actual procurement demand — verify that ceftriaxone sodium and direct injectable antibiotics are the intended focus before resource commitment.